A Strategy Built for Impact,
A Team Built for Growth

Our investment strategy is rooted in identifying and scaling high-potential companies across key life sciences sub-sectors, focusing on cutting-edge technologies with the power to transform patient outcomes and reshape markets.

Our team sets us apart: a group of seasoned entrepreneurs, operators, and investors who bring deep industry expertise and a hands-on approach. From initial investment through exit, we partner closely with founders to accelerate growth, unlock value, and build lasting businesses that make a difference.

Mask Group 5

Kineticos Capital
Partners Fund Series

The Kineticos Capital Partners fund series targets lower mid-market pharma services companies. With a focus on driving organic growth, expanding offerings, executing strategic acquisitions, and pursuing international opportunities, our fund partners with management teams to scale platforms into market leaders.

Learn More
Mask Group 1

Kineticos AMR Accelerator Series

The AMR Accelerator Fund is dedicated to combating antimicrobial resistance by investing in early-stage innovators. We back visionary teams focused on solving one of healthcare’s most pressing global challenges through breakthrough technologies.

Learn More
Mask Group 9 (2)

Kineticos Disruptor Fund Series

The Kineticos Disruptor Fund series invests in early-stage life science companies advancing groundbreaking technologies to treat cancer, neurodegenerative, and rare diseases. We support leading-edge founders pushing the boundaries of science to create the next wave of patient-focused innovation.

Learn More

New From Kineticos